SlideShare a Scribd company logo
What makes a systematic review
systematic? Epidemiologic perspectives
ANNA SIDORCHUK, MD, PHD, RESEARCH COORDINATOR
KAROLINSKA INSTITUTET
DEPARTMENT OF PUBLIC HEALTH SCIENCES
ANNA.SIDORCHUK@KI.SE
THE EPIDEMIOLOGY PHD PROGRAM SEMINAR
APRIL 29, 2013
Outline of the speech
 Non-systematic vs. systematic review
 Why do systematic reviews? What is the added value?
 PRISMA/MOOSE/AMSTAR guidelines and checklists
 Randomized vs. observational data
 Process (criteria, optimize search, determine data to be
abstracted, quality score)
Anna Sidorchuk 2
30 april 2013Anna Sidorchuk
Primary data versus secondary data
 Traditionally, researchers collect and analyze their own data
(referred to as primary data)
 Secondary data analysis is based on data collected by someone
else (or reanalysis of your own published data)
 Systematic review is one of the ways to analyze secondary data
Systematic review - systematic, qualitative review of published
research in a particular field
Adapted from: ESRC Workshop, Researcher Development Initiative, Department of Education, University of Oxford
30 april 2013Anna Sidorchuk
What The Lancet thinks about
systematic reviews
In 2005, the editors wrote:
“. . . we will require authors of clinical trials submitted to The
Lancet to include a clear summary of previous research findings,
and to explain how their trial’s findings affect this summary. The
relation between existing and new evidence should be illustrated
by direct reference to an existing systematic review and meta-
analysis…”
Stages of waste in the production and reporting
of research evidence relevant to clinicians and
patients by Chalmers and Glasziou (Lancet, vol. 374, 2009)
Anna Sidorchuk 5
30 april 2013Anna Sidorchuk
Why do we do systematic reviews?
 To help busy clinicians to summarize current knowledge in
relation to the area of interest
 To provide high-quality research evidence to guide clinical
practice
 To support clinical decision-making
 To support research proposals
30 april 2013Anna Sidorchuk
How systematic review can help busy
clinicians?
By systematically:
 identifying,
 appraising,
 synthesizing,
 and, if appropriate, statistically combining studies on a
specific topic
30 april 2013Anna Sidorchuk
In classifications of levels of evidence,
systematic reviews are included in the highest level of
evidence
Hierarchy of evidence: a framework for ranking
evidence evaluating healthcare interventions
Journal of Clinical Nursing
Volume 12, Issue 1, pages 77-84, 20 DEC 2002 DOI: 10.1046/j.1365-2702.2003.00662.x
http://onlinelibrary.wiley.com/doi/10.1046/j.1365-2702.2003.00662.x/full#f1
30 april 2013Anna Sidorchuk
Meta-analysis
 A statistical method to combine findings across studies
 Should be considered within the framework of systematic reviews
review needs to use a systematic approach to minimize bias, address
the issues of the completeness of the evidence, quality of studies
and combinability of studies
Meta-analysis - the statistical pooling of the results of
studies that are part of a systematic review
When systematic review is required?
 Before undertaking a systematic review it is necessary to
check whether there are already existing or ongoing reviews,
and whether a new review is justified
 Search:
the Database of Abstracts of Reviews of Effects (DARE)
 the Cochrane Database of Systematic Reviews (CDSR)
30 april 2013Anna Sidorchuk
Adapted from: Systematic Reviews. CRD’s guidance for undertaking reviews in health care (2009). Centre for Reviews and
Dissemination, University of York. ISBN 978-1-900640-47-3.
When is meta-analysis appropriate?
 There exists a critical mass of comparable studies designed to
address a common research question
 Data are presented in a form that allows the meta-analyst to
compute an effect size for each study
 Characteristics of each study are described in sufficient detail
to allow meta-analysts to compare characteristics of different
studies and to judge the quality of each study
30 april 2013Anna Sidorchuk
Systematic reviews vs. non-systematic
 Compared to traditional literature reviews:
there is a definite methodology employed in the research analysis
(more like that used in primary research); and
the results of the included studies are quantified to a standard metric
thus allowing for statistical techniques for further analysis.
 Therefore process of reviewing research literature is more
objective, transparent, and replicable; less biased and
idiosyncratic to the whims of a particular researcher
30 april 2013Anna Sidorchuk
Systematic reviews vs. non-systematic
Feature Systematic review Narrative review
Question Often a focused one question Often broad in scope
Sources and search Comprehensive sources and
explicit search strategy
Not usually specified,
potentially biased
Selection Criterion-based selection,
uniformly applied
Not usually specified,
potentially biased
Appraisal Rigorous critical appraisal Variable
Synthesis
Qualitative summary that
includes statistical synthesis
(meta-analysis)
Often a qualitative summary
Inferences Usually evidence-based Sometimes evidence-based
Anna Sidorchuk 14
Adapted from: Y Yuan and R H Hunt, Am J Gastroenterol 2009; 104:1086–1092; doi:10.1038/ajg.2009.118
18 September, 2009Anna Sidorchuk 15
Increase in the number of published
meta-analyses (PubMed references)
Publication year
• The essence of good science is replicable and generalisable results
Do we get the same answer to research questions when we run the study again?
• The primary aims of meta-analysis is to test the generalisability of results
across a set of studies designed to answer the same research question
Are the results consistent? If not, what are the differences in the studies that explain
the lack of consistency?
Why are systematic review and meta-
analysis important?
30 april 2013Anna Sidorchuk
When there is systematic variation in outcomes from different studies,
meta-analysis tries to explain these differences in terms of study
characteristics:
measures used
study design
participant characteristics
controls for potential bias
etc.
If the results of individual studies are
inconclusive or controversial…
30 april 2013Anna Sidorchuk
“… doing a meta-analysis is easy,
doing one well is hard.”
Ingram Olkin, Stanford University
Benefits of systematic reviews, incl. meta-
analysis
 Increased power: by combining information from many
individual studies, the meta-analyst is able to detect systematic
trends not obvious in the individual studies
 Conclusions based on the set of studies are likely to be more
accurate than any one study
30 april 2013Anna Sidorchuk
Benefits of systematic reviews, incl. meta-
analysis
 Improved precision: based on information from many studies,
the meta-analyst can provide a more precise estimate of the
population effect size (and a confidence interval)
 Provides potential corrections for potential biases,
measurement error and other possible artefacts
 Identifies directions for further primary studies to address
unresolved issues
30 april 2013Anna Sidorchuk
Benefits of systematic reviews, incl.
meta-analysis
 Typically there is study-to-study variation in results. When
this is the case, the meta-analyst can explore what
characteristics of the studies explain these differences (e.g.,
study design) in ways not easy to do in individual studies
 Easy to interpret summary statistics (useful if communicating
findings to a non-academic audience)
30 april 2013Anna Sidorchuk
Limitations of systematic reviews, incl.
meta-analysis
 Comparing apples and oranges
 Quality of the studies included in the meta-analysis
 What to do when studies don’t report sufficient information
(e.g., “non-significant” findings)?
 Including multiple outcomes in the analysis (e.g., different
achievement scores)
 Publication bias
22
Limitations of systematic reviews, incl.
meta-analysis
 Meta-analysis conclusions may still differ if different studies
are sampled or excluded for different reasons
 Need to be explicit
 Quality standards
 Inappropriate handling of data can lead to wrong conclusions
 Sample size consideration
23
Publication bias
 Studies that are published are more likely to report
statistically significant findings. This is a source of potential
bias
30 april 2013Anna Sidorchuk
Publication bias
 The debate about using only published studies:
peer-reviewed studies are presumably of a higher quality
VERSUS
significant findings are more likely to be published than non-
significant findings
 There is no agreed upon solution. However, one should retrieve all studies
that meet the eligibility criteria, and be explicit with how they dealt with
publication bias. Some methods for dealing with publication bias have
been developed (e.g., Fail-safe N, Trim and Fill method)
30 april 2013Anna Sidorchuk
RCT vs. observational studies
 Both are fine as long as all the methodological issues are
addressed
 If your focus is effect of therapy or prevention – use RCTs
 If you are interested in prognosis, etiology, adverse
effects, association between risk factors and outcomes –
use observational studies
 Fine to use both types of studies in the same review
Anna Sidorchuk 26
Steps in a meta-analysis
Establish
research
question
Define
relevant
studies
Develop
code
materials
Locate and
collate
studies
Pilot coding;
coding
Data entry
and effect
size
calculation
Main
analyses
Supplementar
y analyses
30 april 2013Anna Sidorchuk Adapted from: ESRC Workshop, Researcher Development Initiative, Department of Education, University of Oxford
Practical tips
 Define all key elements (PICO model) a priory
 Formulate the research question as clear as possible
 Make an agreement with all your co-authors on the key elements
 If needed ask the experts in the area of outcome or/and exposure for
advice
 Keep everything in the protocol
 When writing an article include the elements in the aim
30 april 2013Anna Sidorchuk
Practical tips
 Define all inclusion/exclusion criteria and components of search a priory
 Make criteria and the components as clear as possible, but feel free to
make some changes during the actual literature search (usually due to
availability of data, e.g. if only retrospective studies are available on the
issue, or no info on ethnicity, etc)
 Make an agreement with all co-authors on abovementioned
 Again, keep everything in the review protocol
30 april 2013Anna Sidorchuk
Practical tips
 Define coding and form for data extraction a priory
 Make an agreement with all co-authors on abovementioned
 If use Excel for data extraction and, therefore, for coding, keep the legend
for each coding element within the same file on the separate sheet
 As an alternative – use Access
 Keep everything in the review protocol!
30 april 2013Anna Sidorchuk
Practical tips
 Define as detailed as possible by reading other meta-analysis and
systematic reviews on the similar outcome(s) and exposure(s):
 All key words
 MESH terms
 Define the electronic sources to be used for your search
 Ask librarians for advice on search strategy and technic
 Define if grey literature will be included
 Keep everything in the protocol!!!
30 april 2013Anna Sidorchuk
Critical issue
Quality, quality, quality!
30 april 2013Anna Sidorchuk
Quality Standards in Systematic
reviews and Meta-Analysis
 Several organizations work on this
Cochrane collaboration
http://www.cochrane.org
Campbell collaboration
http://www.campbellcollaboration.org
 Consort: Consolidated Standards of Reporting Trials, includes
Quorum: Quality of Reporting of Meta-analyses group
http://www.consort-statement.org/mod_product/uploads/QUOROM
Statement 1999.pdf
 PRISMA (Preferred Reporting Items for Systematic reviews and Meta-
Analyses), AMSTAR (A measurement tool to assess systematic reviews)
30 april 2013Anna Sidorchuk
30 april 2013Anna Sidorchuk
PRISMA: Checklist of items to include when reporting a systematic review or meta-
analysis.
Section/Topic # Checklist Item
Reported
on Page #
TITLE
Title 1 Identify the report as a systematic review, meta-analysis, or both.
ABSTRACT
Structured
summary
2
Provide a structured summary including, as applicable:
background; objectives; data sources; study eligibility criteria,
participants, and interventions; study appraisal and synthesis
methods; results; limitations; conclusions and implications of key
findings; systematic review registration number.
INTRODUCTION
Rationale 3
Describe the rationale for the review in the context of what is
already known.
Objectives 4
Provide an explicit statement of questions being addressed with
reference to participants, interventions, comparisons, outcomes,
and study design (PICOS).
30 april 2013Anna Sidorchuk
PRISMA: Checklist of items to include when reporting a systematic review or meta-
analysis.
Section/Topic # Checklist Item
Reported
on Page #
METHODS
Protocol and
registration
5
Indicate if a review protocol exists, if and where it can be
accessed (e.g., Web address), and, if available, provide
registration information including registration number.
Eligibility
criteria
6
Specify study characteristics (e.g., PICOS, length of follow-
up) and report characteristics (e.g., years considered,
language, publication status) used as criteria for eligibility,
giving rationale.
Information
sources
7
Describe all information sources (e.g., databases with dates of
coverage, contact with study authors to identify additional
studies) in the search and date last searched.
Search 8
Present full electronic search strategy for at least one
database, including any limits used, such that it could be
repeated.
Study selection 9
State the process for selecting studies (i.e., screening,
eligibility, included in systematic review, and, if applicable,
included in the meta-analysis).
Data collection
process
10
Describe method of data extraction from reports (e.g., piloted
forms, independently, in duplicate) and any processes for
obtaining and confirming data from investigators.
Data items 11
List and define all variables for which data were sought (e.g.,
PICOS, funding sources) and any assumptions and
simplifications made.
30 april 2013Anna Sidorchuk
PRISMA: Checklist of items to include when reporting a systematic review or meta-
analysis.
Section/Topic # Checklist Item
Reported
on Page #
METHODS
Risk of bias in
individual studies
12
Describe methods used for assessing risk of bias of
individual studies (including specification of whether this
was done at the study or outcome level), and how this
information is to be used in any data synthesis.
Summary
measures
13
State the principal summary measures (e.g., risk ratio,
difference in means).
Synthesis of
results
14
Describe the methods of handling data and combining
results of studies, if done, including measures of consistency
(e.g., I2
) for each meta-analysis.
Risk of bias
across studies
15
Specify any assessment of risk of bias that may affect the
cumulative evidence (e.g., publication bias, selective
reporting within studies).
Additional
analyses
16
Describe methods of additional analyses (e.g., sensitivity or
subgroup analyses, meta-regression), if done, indicating
which were pre-specified.
30 april 2013Anna Sidorchuk
PRISMA: Checklist of items to include when reporting a systematic review or meta-
analysis.
Section/Topic # Checklist Item
Reported
on Page #
RESULTS
Study selection 17
Give numbers of studies screened, assessed for eligibility,
and included in the review, with reasons for exclusions at
each stage, ideally with a flow diagram.
Study
characteristics
18
For each study, present characteristics for which data were
extracted (e.g., study size, PICOS, follow-up period) and
provide the citations.
Risk of bias
within studies
19
Present data on risk of bias of each study and, if available,
any outcome-level assessment (see Item 12).
Results of
individual studies
20
For all outcomes considered (benefits or harms), present, for
each study: (a) simple summary data for each intervention
group and (b) effect estimates and confidence intervals,
ideally with a forest plot.
Synthesis of
results
21
Present results of each meta-analysis done, including
confidence intervals and measures of consistency.
Risk of bias
across studies
22
Present results of any assessment of risk of bias across
studies (see Item 15).
Additional
analysis
23
Give results of additional analyses, if done (e.g., sensitivity
or subgroup analyses, meta-regression [see Item 16]).
30 april 2013Anna Sidorchuk
PRISMA: Checklist of items to include when reporting a systematic review or meta-
analysis.
Section/Topic # Checklist Item
Reported
on Page #
DISCUSSION
Summary of
evidence
24
Summarize the main findings including the strength of
evidence for each main outcome; consider their relevance to
key groups (e.g., health care providers, users, and policy
makers).
Limitations 25
Discuss limitations at study and outcome level (e.g., risk of
bias), and at review level (e.g., incomplete retrieval of
identified research, reporting bias).
Conclusions 26
Provide a general interpretation of the results in the context of
other evidence, and implications for future research.
FUNDING
Funding 27
Describe sources of funding for the systematic review and
other support (e.g., supply of data); role of funders for the
systematic review.
Quality Assessment of Primary Studies
 A common practice is to assign a quality score to primary
studies
Preferably based on an explicit checklist usually
 The judgment to include or exclude a study must be stated
and justified explicitly
 This judgment is mostly based on quantitative criteria, but
involves some subjectivity
30 april 2013Anna Sidorchuk
NEWCASTLE - OTTAWA QUALITY ASSESSMENT SCALE
CASE CONTROL STUDIES
 Note: A study can be awarded a maximum of one star for each numbered item within the Selection and Exposure
categories. A maximum of two stars can be given for Comparability.
Selection
1) Is the case definition adequate?
a) yes, with independent validation ¯
b) yes, eg record linkage or based on self reports
c) no description
2) Representativeness of the cases
a) consecutive or obviously representative series of cases ¯
b) potential for selection biases or not stated
3) Selection of Controls
a) community controls ¯
b) hospital controls
c) no description
4) Definition of Controls
a) no history of disease (endpoint) 
b) no description of source
30 april 2013Anna Sidorchuk
NEWCASTLE - OTTAWA QUALITY ASSESSMENT SCALE
CASE CONTROL STUDIES
Comparability
1) Comparability of cases and controls on the basis of the design or analysis
a) study controls for _______________ (Select the most important factor.) ¯
b) study controls for any additional factor ¯ (This criteria could be modified to indicate specific control for a
second important factor.)
Exposure
1) Ascertainment of exposure
a) secure record (eg surgical records) ¯
b) structured interview where blind to case/control status ¯
c) interview not blinded to case/control status
d) written self report or medical record only
e) no description
2) Same method of ascertainment for cases and controls
a) yes ¯
b) no
3) Non-Response rate
a) same rate for both groups ¯
b) non respondents described
c) rate different and no designation
30 april 2013Anna Sidorchuk
“Ugly face” of systematic reviews and
meta-analyses
 Can be misleading
 Can be misused
30 april 2013Anna Sidorchuk

More Related Content

What's hot

Seminaar on meta analysis
Seminaar on meta analysisSeminaar on meta analysis
Seminaar on meta analysis
Preeti Rai
 
COPE General Intro Core Practices
COPE General Intro Core PracticesCOPE General Intro Core Practices
COPE General Intro Core Practices
C0pe
 
Systematic review and meta analaysis course - part 1
Systematic review and meta analaysis course - part 1Systematic review and meta analaysis course - part 1
Systematic review and meta analaysis course - part 1
Ahmed Negida
 
Metaanalysis copy
Metaanalysis    copyMetaanalysis    copy
Metaanalysis copy
Amandeep Kaur
 
Literature monitoring for pv what are we doing at galderma elsevier webinar
Literature monitoring for pv   what are we doing at galderma elsevier webinarLiterature monitoring for pv   what are we doing at galderma elsevier webinar
Literature monitoring for pv what are we doing at galderma elsevier webinar
Ann-Marie Roche
 
Journal knowhows
Journal  knowhows Journal  knowhows
Journal knowhows
Prof Viyatprajna Acharya
 
Critical appraisal of published article
Critical appraisal of published articleCritical appraisal of published article
Critical appraisal of published article
Yogesh Singhal
 
Be aware fo predatory journal
Be aware fo predatory journalBe aware fo predatory journal
Be aware fo predatory journal
Kassu Jilcha (PhD)
 
Systematic Review: Beginner's Guide
Systematic Review: Beginner's Guide Systematic Review: Beginner's Guide
Systematic Review: Beginner's Guide
Saee Deshpamde
 
Basics of Systematic Review and Meta-analysis: Part 2
Basics of Systematic Review and Meta-analysis: Part 2Basics of Systematic Review and Meta-analysis: Part 2
Basics of Systematic Review and Meta-analysis: Part 2
Rizwan S A
 
Critical appraisal of a journal article
Critical appraisal of a journal articleCritical appraisal of a journal article
Critical appraisal of a journal article
DrSahilKumar
 
Meta-Analysis -- Introduction.pptx
Meta-Analysis -- Introduction.pptxMeta-Analysis -- Introduction.pptx
Meta-Analysis -- Introduction.pptx
ACSRM
 
Predatory publishing
Predatory publishingPredatory publishing
Predatory publishing
Roxanne Missingham
 
Plagiarism
PlagiarismPlagiarism
Introduction to Systematic Reviews
Introduction to Systematic ReviewsIntroduction to Systematic Reviews
Introduction to Systematic Reviews
Laura Koltutsky
 
Critical appraisal of published medical research
Critical appraisal of published medical researchCritical appraisal of published medical research
Critical appraisal of published medical research
Tarek Tawfik Amin
 
Introduction to systematic reviews
Introduction to systematic reviewsIntroduction to systematic reviews
Introduction to systematic reviews
Omar Midani
 
Research question
Research questionResearch question
Research question
Tarek Tawfik Amin
 
Systematic review
Systematic reviewSystematic review
Systematic review
Aboubakr Elnashar
 
Systematic Reviews: the process, quantitative, qualitative and mixed methods ...
Systematic Reviews: the process, quantitative, qualitative and mixed methods ...Systematic Reviews: the process, quantitative, qualitative and mixed methods ...
Systematic Reviews: the process, quantitative, qualitative and mixed methods ...
healthlibaust2012
 

What's hot (20)

Seminaar on meta analysis
Seminaar on meta analysisSeminaar on meta analysis
Seminaar on meta analysis
 
COPE General Intro Core Practices
COPE General Intro Core PracticesCOPE General Intro Core Practices
COPE General Intro Core Practices
 
Systematic review and meta analaysis course - part 1
Systematic review and meta analaysis course - part 1Systematic review and meta analaysis course - part 1
Systematic review and meta analaysis course - part 1
 
Metaanalysis copy
Metaanalysis    copyMetaanalysis    copy
Metaanalysis copy
 
Literature monitoring for pv what are we doing at galderma elsevier webinar
Literature monitoring for pv   what are we doing at galderma elsevier webinarLiterature monitoring for pv   what are we doing at galderma elsevier webinar
Literature monitoring for pv what are we doing at galderma elsevier webinar
 
Journal knowhows
Journal  knowhows Journal  knowhows
Journal knowhows
 
Critical appraisal of published article
Critical appraisal of published articleCritical appraisal of published article
Critical appraisal of published article
 
Be aware fo predatory journal
Be aware fo predatory journalBe aware fo predatory journal
Be aware fo predatory journal
 
Systematic Review: Beginner's Guide
Systematic Review: Beginner's Guide Systematic Review: Beginner's Guide
Systematic Review: Beginner's Guide
 
Basics of Systematic Review and Meta-analysis: Part 2
Basics of Systematic Review and Meta-analysis: Part 2Basics of Systematic Review and Meta-analysis: Part 2
Basics of Systematic Review and Meta-analysis: Part 2
 
Critical appraisal of a journal article
Critical appraisal of a journal articleCritical appraisal of a journal article
Critical appraisal of a journal article
 
Meta-Analysis -- Introduction.pptx
Meta-Analysis -- Introduction.pptxMeta-Analysis -- Introduction.pptx
Meta-Analysis -- Introduction.pptx
 
Predatory publishing
Predatory publishingPredatory publishing
Predatory publishing
 
Plagiarism
PlagiarismPlagiarism
Plagiarism
 
Introduction to Systematic Reviews
Introduction to Systematic ReviewsIntroduction to Systematic Reviews
Introduction to Systematic Reviews
 
Critical appraisal of published medical research
Critical appraisal of published medical researchCritical appraisal of published medical research
Critical appraisal of published medical research
 
Introduction to systematic reviews
Introduction to systematic reviewsIntroduction to systematic reviews
Introduction to systematic reviews
 
Research question
Research questionResearch question
Research question
 
Systematic review
Systematic reviewSystematic review
Systematic review
 
Systematic Reviews: the process, quantitative, qualitative and mixed methods ...
Systematic Reviews: the process, quantitative, qualitative and mixed methods ...Systematic Reviews: the process, quantitative, qualitative and mixed methods ...
Systematic Reviews: the process, quantitative, qualitative and mixed methods ...
 

Viewers also liked

Amsterdam 2012 - one stage meta-analysis
Amsterdam 2012 - one stage meta-analysisAmsterdam 2012 - one stage meta-analysis
Amsterdam 2012 - one stage meta-analysis
Evangelos Kontopantelis
 
ForskarFredag 2013
ForskarFredag 2013ForskarFredag 2013
ForskarFredag 2013
adinafeldman
 
KI Evolution Framtidsradet alumni event 20130531
KI Evolution Framtidsradet alumni event 20130531KI Evolution Framtidsradet alumni event 20130531
KI Evolution Framtidsradet alumni event 20130531
adinafeldman
 
Adina feldman doctoral thesis defence presentation
Adina feldman doctoral thesis defence presentationAdina feldman doctoral thesis defence presentation
Adina feldman doctoral thesis defence presentation
adinafeldman
 
Systematic review ppt
Systematic review pptSystematic review ppt
Systematic review ppt
Basil Asay
 
Systematic review
Systematic reviewSystematic review
Systematic review
Khalid Mahmood
 

Viewers also liked (6)

Amsterdam 2012 - one stage meta-analysis
Amsterdam 2012 - one stage meta-analysisAmsterdam 2012 - one stage meta-analysis
Amsterdam 2012 - one stage meta-analysis
 
ForskarFredag 2013
ForskarFredag 2013ForskarFredag 2013
ForskarFredag 2013
 
KI Evolution Framtidsradet alumni event 20130531
KI Evolution Framtidsradet alumni event 20130531KI Evolution Framtidsradet alumni event 20130531
KI Evolution Framtidsradet alumni event 20130531
 
Adina feldman doctoral thesis defence presentation
Adina feldman doctoral thesis defence presentationAdina feldman doctoral thesis defence presentation
Adina feldman doctoral thesis defence presentation
 
Systematic review ppt
Systematic review pptSystematic review ppt
Systematic review ppt
 
Systematic review
Systematic reviewSystematic review
Systematic review
 

Similar to Updated - What makes systematic review systematic - Anna Sidorchuk

Systematic and Scoping Reviews.pptx
Systematic and Scoping Reviews.pptxSystematic and Scoping Reviews.pptx
Systematic and Scoping Reviews.pptx
LauraLarreaMantilla
 
A research study Writing a Systematic Review in Clinical Research – Pubrica
A research study Writing a Systematic Review in Clinical Research – PubricaA research study Writing a Systematic Review in Clinical Research – Pubrica
A research study Writing a Systematic Review in Clinical Research – Pubrica
Pubrica
 
A research study writing a systematic review in clinical research – pubrica
A research study writing a systematic review in clinical research – pubricaA research study writing a systematic review in clinical research – pubrica
A research study writing a systematic review in clinical research – pubrica
Pubrica
 
What is a Systematic Review? - Pubrica
What is a Systematic Review? - PubricaWhat is a Systematic Review? - Pubrica
What is a Systematic Review? - Pubrica
Pubrica
 
Research design and methodology | Research design and methodology | Research ...
Research design and methodology | Research design and methodology | Research ...Research design and methodology | Research design and methodology | Research ...
Research design and methodology | Research design and methodology | Research ...
Pubrica
 
Comparison and complimentary between qualitative and quantitative approaches
Comparison and complimentary between qualitative and quantitative approachesComparison and complimentary between qualitative and quantitative approaches
Comparison and complimentary between qualitative and quantitative approaches
Dr. Rania Al- Jilani
 
Level of Evidence- Dina Hudiya Nadana Lubis.pptx
Level of Evidence- Dina Hudiya Nadana Lubis.pptxLevel of Evidence- Dina Hudiya Nadana Lubis.pptx
Level of Evidence- Dina Hudiya Nadana Lubis.pptx
dina410715
 
Systematic Review-Scoping Review
Systematic Review-Scoping ReviewSystematic Review-Scoping Review
Systematic Review-Scoping Review
Neda Firouraghi
 
studydesigns-180726100410.pdf
studydesigns-180726100410.pdfstudydesigns-180726100410.pdf
studydesigns-180726100410.pdf
yonataneshete
 
Study designs, Epidemiological study design, Types of studies
Study designs, Epidemiological study design, Types of studiesStudy designs, Epidemiological study design, Types of studies
Study designs, Epidemiological study design, Types of studies
Dr Lipilekha Patnaik
 
Systematic review.pptx
Systematic review.pptxSystematic review.pptx
Systematic review.pptx
Pubricahealthcare
 
Systematic Reviews Class 4c
Systematic Reviews Class 4cSystematic Reviews Class 4c
Systematic Reviews Class 4c
guestf5d7ac
 
Critical appraisal 2012 updated
Critical appraisal 2012 updatedCritical appraisal 2012 updated
Critical appraisal 2012 updated
sanghagirl
 
Primary secf2016
Primary secf2016Primary secf2016
Primary secf2016
sherfel
 
research design sonal ppt
research design sonal pptresearch design sonal ppt
research design sonal ppt
Venu Goud
 
Lesson 6 research methodology
Lesson 6 research methodologyLesson 6 research methodology
Lesson 6 research methodology
Dr. P.B.Dharmasena
 
Stages Involved in Research Project.pptx
Stages Involved in Research Project.pptxStages Involved in Research Project.pptx
Stages Involved in Research Project.pptx
LawalBelloDanchadi
 
Research report
Research reportResearch report
Research report
Jayaprakash CR
 
An introduction to research methods
An introduction to research methodsAn introduction to research methods
An introduction to research methods
teachner
 
introtoresearch.pdf
introtoresearch.pdfintrotoresearch.pdf
introtoresearch.pdf
obedcudjoe1
 

Similar to Updated - What makes systematic review systematic - Anna Sidorchuk (20)

Systematic and Scoping Reviews.pptx
Systematic and Scoping Reviews.pptxSystematic and Scoping Reviews.pptx
Systematic and Scoping Reviews.pptx
 
A research study Writing a Systematic Review in Clinical Research – Pubrica
A research study Writing a Systematic Review in Clinical Research – PubricaA research study Writing a Systematic Review in Clinical Research – Pubrica
A research study Writing a Systematic Review in Clinical Research – Pubrica
 
A research study writing a systematic review in clinical research – pubrica
A research study writing a systematic review in clinical research – pubricaA research study writing a systematic review in clinical research – pubrica
A research study writing a systematic review in clinical research – pubrica
 
What is a Systematic Review? - Pubrica
What is a Systematic Review? - PubricaWhat is a Systematic Review? - Pubrica
What is a Systematic Review? - Pubrica
 
Research design and methodology | Research design and methodology | Research ...
Research design and methodology | Research design and methodology | Research ...Research design and methodology | Research design and methodology | Research ...
Research design and methodology | Research design and methodology | Research ...
 
Comparison and complimentary between qualitative and quantitative approaches
Comparison and complimentary between qualitative and quantitative approachesComparison and complimentary between qualitative and quantitative approaches
Comparison and complimentary between qualitative and quantitative approaches
 
Level of Evidence- Dina Hudiya Nadana Lubis.pptx
Level of Evidence- Dina Hudiya Nadana Lubis.pptxLevel of Evidence- Dina Hudiya Nadana Lubis.pptx
Level of Evidence- Dina Hudiya Nadana Lubis.pptx
 
Systematic Review-Scoping Review
Systematic Review-Scoping ReviewSystematic Review-Scoping Review
Systematic Review-Scoping Review
 
studydesigns-180726100410.pdf
studydesigns-180726100410.pdfstudydesigns-180726100410.pdf
studydesigns-180726100410.pdf
 
Study designs, Epidemiological study design, Types of studies
Study designs, Epidemiological study design, Types of studiesStudy designs, Epidemiological study design, Types of studies
Study designs, Epidemiological study design, Types of studies
 
Systematic review.pptx
Systematic review.pptxSystematic review.pptx
Systematic review.pptx
 
Systematic Reviews Class 4c
Systematic Reviews Class 4cSystematic Reviews Class 4c
Systematic Reviews Class 4c
 
Critical appraisal 2012 updated
Critical appraisal 2012 updatedCritical appraisal 2012 updated
Critical appraisal 2012 updated
 
Primary secf2016
Primary secf2016Primary secf2016
Primary secf2016
 
research design sonal ppt
research design sonal pptresearch design sonal ppt
research design sonal ppt
 
Lesson 6 research methodology
Lesson 6 research methodologyLesson 6 research methodology
Lesson 6 research methodology
 
Stages Involved in Research Project.pptx
Stages Involved in Research Project.pptxStages Involved in Research Project.pptx
Stages Involved in Research Project.pptx
 
Research report
Research reportResearch report
Research report
 
An introduction to research methods
An introduction to research methodsAn introduction to research methods
An introduction to research methods
 
introtoresearch.pdf
introtoresearch.pdfintrotoresearch.pdf
introtoresearch.pdf
 

Recently uploaded

CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
rightmanforbloodline
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
bkling
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
70KRISHPATEL
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
rightmanforbloodline
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
SwisschemDerma
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
arahmanzai5
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
KafrELShiekh University
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 

Recently uploaded (20)

CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 

Updated - What makes systematic review systematic - Anna Sidorchuk

  • 1. What makes a systematic review systematic? Epidemiologic perspectives ANNA SIDORCHUK, MD, PHD, RESEARCH COORDINATOR KAROLINSKA INSTITUTET DEPARTMENT OF PUBLIC HEALTH SCIENCES ANNA.SIDORCHUK@KI.SE THE EPIDEMIOLOGY PHD PROGRAM SEMINAR APRIL 29, 2013
  • 2. Outline of the speech  Non-systematic vs. systematic review  Why do systematic reviews? What is the added value?  PRISMA/MOOSE/AMSTAR guidelines and checklists  Randomized vs. observational data  Process (criteria, optimize search, determine data to be abstracted, quality score) Anna Sidorchuk 2
  • 3. 30 april 2013Anna Sidorchuk Primary data versus secondary data  Traditionally, researchers collect and analyze their own data (referred to as primary data)  Secondary data analysis is based on data collected by someone else (or reanalysis of your own published data)  Systematic review is one of the ways to analyze secondary data Systematic review - systematic, qualitative review of published research in a particular field Adapted from: ESRC Workshop, Researcher Development Initiative, Department of Education, University of Oxford
  • 4. 30 april 2013Anna Sidorchuk What The Lancet thinks about systematic reviews In 2005, the editors wrote: “. . . we will require authors of clinical trials submitted to The Lancet to include a clear summary of previous research findings, and to explain how their trial’s findings affect this summary. The relation between existing and new evidence should be illustrated by direct reference to an existing systematic review and meta- analysis…”
  • 5. Stages of waste in the production and reporting of research evidence relevant to clinicians and patients by Chalmers and Glasziou (Lancet, vol. 374, 2009) Anna Sidorchuk 5
  • 6. 30 april 2013Anna Sidorchuk Why do we do systematic reviews?  To help busy clinicians to summarize current knowledge in relation to the area of interest  To provide high-quality research evidence to guide clinical practice  To support clinical decision-making  To support research proposals
  • 7. 30 april 2013Anna Sidorchuk How systematic review can help busy clinicians? By systematically:  identifying,  appraising,  synthesizing,  and, if appropriate, statistically combining studies on a specific topic
  • 8. 30 april 2013Anna Sidorchuk In classifications of levels of evidence, systematic reviews are included in the highest level of evidence
  • 9. Hierarchy of evidence: a framework for ranking evidence evaluating healthcare interventions Journal of Clinical Nursing Volume 12, Issue 1, pages 77-84, 20 DEC 2002 DOI: 10.1046/j.1365-2702.2003.00662.x http://onlinelibrary.wiley.com/doi/10.1046/j.1365-2702.2003.00662.x/full#f1
  • 10. 30 april 2013Anna Sidorchuk Meta-analysis  A statistical method to combine findings across studies  Should be considered within the framework of systematic reviews review needs to use a systematic approach to minimize bias, address the issues of the completeness of the evidence, quality of studies and combinability of studies Meta-analysis - the statistical pooling of the results of studies that are part of a systematic review
  • 11. When systematic review is required?  Before undertaking a systematic review it is necessary to check whether there are already existing or ongoing reviews, and whether a new review is justified  Search: the Database of Abstracts of Reviews of Effects (DARE)  the Cochrane Database of Systematic Reviews (CDSR) 30 april 2013Anna Sidorchuk Adapted from: Systematic Reviews. CRD’s guidance for undertaking reviews in health care (2009). Centre for Reviews and Dissemination, University of York. ISBN 978-1-900640-47-3.
  • 12. When is meta-analysis appropriate?  There exists a critical mass of comparable studies designed to address a common research question  Data are presented in a form that allows the meta-analyst to compute an effect size for each study  Characteristics of each study are described in sufficient detail to allow meta-analysts to compare characteristics of different studies and to judge the quality of each study 30 april 2013Anna Sidorchuk
  • 13. Systematic reviews vs. non-systematic  Compared to traditional literature reviews: there is a definite methodology employed in the research analysis (more like that used in primary research); and the results of the included studies are quantified to a standard metric thus allowing for statistical techniques for further analysis.  Therefore process of reviewing research literature is more objective, transparent, and replicable; less biased and idiosyncratic to the whims of a particular researcher 30 april 2013Anna Sidorchuk
  • 14. Systematic reviews vs. non-systematic Feature Systematic review Narrative review Question Often a focused one question Often broad in scope Sources and search Comprehensive sources and explicit search strategy Not usually specified, potentially biased Selection Criterion-based selection, uniformly applied Not usually specified, potentially biased Appraisal Rigorous critical appraisal Variable Synthesis Qualitative summary that includes statistical synthesis (meta-analysis) Often a qualitative summary Inferences Usually evidence-based Sometimes evidence-based Anna Sidorchuk 14 Adapted from: Y Yuan and R H Hunt, Am J Gastroenterol 2009; 104:1086–1092; doi:10.1038/ajg.2009.118
  • 15. 18 September, 2009Anna Sidorchuk 15 Increase in the number of published meta-analyses (PubMed references) Publication year
  • 16. • The essence of good science is replicable and generalisable results Do we get the same answer to research questions when we run the study again? • The primary aims of meta-analysis is to test the generalisability of results across a set of studies designed to answer the same research question Are the results consistent? If not, what are the differences in the studies that explain the lack of consistency? Why are systematic review and meta- analysis important? 30 april 2013Anna Sidorchuk
  • 17. When there is systematic variation in outcomes from different studies, meta-analysis tries to explain these differences in terms of study characteristics: measures used study design participant characteristics controls for potential bias etc. If the results of individual studies are inconclusive or controversial… 30 april 2013Anna Sidorchuk
  • 18. “… doing a meta-analysis is easy, doing one well is hard.” Ingram Olkin, Stanford University
  • 19. Benefits of systematic reviews, incl. meta- analysis  Increased power: by combining information from many individual studies, the meta-analyst is able to detect systematic trends not obvious in the individual studies  Conclusions based on the set of studies are likely to be more accurate than any one study 30 april 2013Anna Sidorchuk
  • 20. Benefits of systematic reviews, incl. meta- analysis  Improved precision: based on information from many studies, the meta-analyst can provide a more precise estimate of the population effect size (and a confidence interval)  Provides potential corrections for potential biases, measurement error and other possible artefacts  Identifies directions for further primary studies to address unresolved issues 30 april 2013Anna Sidorchuk
  • 21. Benefits of systematic reviews, incl. meta-analysis  Typically there is study-to-study variation in results. When this is the case, the meta-analyst can explore what characteristics of the studies explain these differences (e.g., study design) in ways not easy to do in individual studies  Easy to interpret summary statistics (useful if communicating findings to a non-academic audience) 30 april 2013Anna Sidorchuk
  • 22. Limitations of systematic reviews, incl. meta-analysis  Comparing apples and oranges  Quality of the studies included in the meta-analysis  What to do when studies don’t report sufficient information (e.g., “non-significant” findings)?  Including multiple outcomes in the analysis (e.g., different achievement scores)  Publication bias 22
  • 23. Limitations of systematic reviews, incl. meta-analysis  Meta-analysis conclusions may still differ if different studies are sampled or excluded for different reasons  Need to be explicit  Quality standards  Inappropriate handling of data can lead to wrong conclusions  Sample size consideration 23
  • 24. Publication bias  Studies that are published are more likely to report statistically significant findings. This is a source of potential bias 30 april 2013Anna Sidorchuk
  • 25. Publication bias  The debate about using only published studies: peer-reviewed studies are presumably of a higher quality VERSUS significant findings are more likely to be published than non- significant findings  There is no agreed upon solution. However, one should retrieve all studies that meet the eligibility criteria, and be explicit with how they dealt with publication bias. Some methods for dealing with publication bias have been developed (e.g., Fail-safe N, Trim and Fill method) 30 april 2013Anna Sidorchuk
  • 26. RCT vs. observational studies  Both are fine as long as all the methodological issues are addressed  If your focus is effect of therapy or prevention – use RCTs  If you are interested in prognosis, etiology, adverse effects, association between risk factors and outcomes – use observational studies  Fine to use both types of studies in the same review Anna Sidorchuk 26
  • 27. Steps in a meta-analysis Establish research question Define relevant studies Develop code materials Locate and collate studies Pilot coding; coding Data entry and effect size calculation Main analyses Supplementar y analyses 30 april 2013Anna Sidorchuk Adapted from: ESRC Workshop, Researcher Development Initiative, Department of Education, University of Oxford
  • 28. Practical tips  Define all key elements (PICO model) a priory  Formulate the research question as clear as possible  Make an agreement with all your co-authors on the key elements  If needed ask the experts in the area of outcome or/and exposure for advice  Keep everything in the protocol  When writing an article include the elements in the aim 30 april 2013Anna Sidorchuk
  • 29. Practical tips  Define all inclusion/exclusion criteria and components of search a priory  Make criteria and the components as clear as possible, but feel free to make some changes during the actual literature search (usually due to availability of data, e.g. if only retrospective studies are available on the issue, or no info on ethnicity, etc)  Make an agreement with all co-authors on abovementioned  Again, keep everything in the review protocol 30 april 2013Anna Sidorchuk
  • 30. Practical tips  Define coding and form for data extraction a priory  Make an agreement with all co-authors on abovementioned  If use Excel for data extraction and, therefore, for coding, keep the legend for each coding element within the same file on the separate sheet  As an alternative – use Access  Keep everything in the review protocol! 30 april 2013Anna Sidorchuk
  • 31. Practical tips  Define as detailed as possible by reading other meta-analysis and systematic reviews on the similar outcome(s) and exposure(s):  All key words  MESH terms  Define the electronic sources to be used for your search  Ask librarians for advice on search strategy and technic  Define if grey literature will be included  Keep everything in the protocol!!! 30 april 2013Anna Sidorchuk
  • 32. Critical issue Quality, quality, quality! 30 april 2013Anna Sidorchuk
  • 33. Quality Standards in Systematic reviews and Meta-Analysis  Several organizations work on this Cochrane collaboration http://www.cochrane.org Campbell collaboration http://www.campbellcollaboration.org  Consort: Consolidated Standards of Reporting Trials, includes Quorum: Quality of Reporting of Meta-analyses group http://www.consort-statement.org/mod_product/uploads/QUOROM Statement 1999.pdf  PRISMA (Preferred Reporting Items for Systematic reviews and Meta- Analyses), AMSTAR (A measurement tool to assess systematic reviews) 30 april 2013Anna Sidorchuk
  • 34. 30 april 2013Anna Sidorchuk PRISMA: Checklist of items to include when reporting a systematic review or meta- analysis. Section/Topic # Checklist Item Reported on Page # TITLE Title 1 Identify the report as a systematic review, meta-analysis, or both. ABSTRACT Structured summary 2 Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number. INTRODUCTION Rationale 3 Describe the rationale for the review in the context of what is already known. Objectives 4 Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).
  • 35. 30 april 2013Anna Sidorchuk PRISMA: Checklist of items to include when reporting a systematic review or meta- analysis. Section/Topic # Checklist Item Reported on Page # METHODS Protocol and registration 5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number. Eligibility criteria 6 Specify study characteristics (e.g., PICOS, length of follow- up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale. Information sources 7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched. Search 8 Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated. Study selection 9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis). Data collection process 10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators. Data items 11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.
  • 36. 30 april 2013Anna Sidorchuk PRISMA: Checklist of items to include when reporting a systematic review or meta- analysis. Section/Topic # Checklist Item Reported on Page # METHODS Risk of bias in individual studies 12 Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis. Summary measures 13 State the principal summary measures (e.g., risk ratio, difference in means). Synthesis of results 14 Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2 ) for each meta-analysis. Risk of bias across studies 15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies). Additional analyses 16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.
  • 37. 30 april 2013Anna Sidorchuk PRISMA: Checklist of items to include when reporting a systematic review or meta- analysis. Section/Topic # Checklist Item Reported on Page # RESULTS Study selection 17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram. Study characteristics 18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations. Risk of bias within studies 19 Present data on risk of bias of each study and, if available, any outcome-level assessment (see Item 12). Results of individual studies 20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group and (b) effect estimates and confidence intervals, ideally with a forest plot. Synthesis of results 21 Present results of each meta-analysis done, including confidence intervals and measures of consistency. Risk of bias across studies 22 Present results of any assessment of risk of bias across studies (see Item 15). Additional analysis 23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 16]).
  • 38. 30 april 2013Anna Sidorchuk PRISMA: Checklist of items to include when reporting a systematic review or meta- analysis. Section/Topic # Checklist Item Reported on Page # DISCUSSION Summary of evidence 24 Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., health care providers, users, and policy makers). Limitations 25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review level (e.g., incomplete retrieval of identified research, reporting bias). Conclusions 26 Provide a general interpretation of the results in the context of other evidence, and implications for future research. FUNDING Funding 27 Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.
  • 39. Quality Assessment of Primary Studies  A common practice is to assign a quality score to primary studies Preferably based on an explicit checklist usually  The judgment to include or exclude a study must be stated and justified explicitly  This judgment is mostly based on quantitative criteria, but involves some subjectivity 30 april 2013Anna Sidorchuk
  • 40. NEWCASTLE - OTTAWA QUALITY ASSESSMENT SCALE CASE CONTROL STUDIES  Note: A study can be awarded a maximum of one star for each numbered item within the Selection and Exposure categories. A maximum of two stars can be given for Comparability. Selection 1) Is the case definition adequate? a) yes, with independent validation ¯ b) yes, eg record linkage or based on self reports c) no description 2) Representativeness of the cases a) consecutive or obviously representative series of cases ¯ b) potential for selection biases or not stated 3) Selection of Controls a) community controls ¯ b) hospital controls c) no description 4) Definition of Controls a) no history of disease (endpoint)  b) no description of source 30 april 2013Anna Sidorchuk
  • 41. NEWCASTLE - OTTAWA QUALITY ASSESSMENT SCALE CASE CONTROL STUDIES Comparability 1) Comparability of cases and controls on the basis of the design or analysis a) study controls for _______________ (Select the most important factor.) ¯ b) study controls for any additional factor ¯ (This criteria could be modified to indicate specific control for a second important factor.) Exposure 1) Ascertainment of exposure a) secure record (eg surgical records) ¯ b) structured interview where blind to case/control status ¯ c) interview not blinded to case/control status d) written self report or medical record only e) no description 2) Same method of ascertainment for cases and controls a) yes ¯ b) no 3) Non-Response rate a) same rate for both groups ¯ b) non respondents described c) rate different and no designation 30 april 2013Anna Sidorchuk
  • 42. “Ugly face” of systematic reviews and meta-analyses  Can be misleading  Can be misused 30 april 2013Anna Sidorchuk